The pharmacology of pain signalling.
Recent advances in pain research illustrate the analytical power of modern neurosciences in a field previously accessible only to methods of systems biology. Novel molecular and cellular biological techniques have changed the face of pain research by detailing the multiplicity of pain transducing and pain suppressive systems which involve neuronal and hormonal systems acting in concert to help the individual to cope with pain. The introduction of concepts of neuronal plasticity in this field has led to important therapeutical consequences. Novel compounds and new regimens for drug treatment to prevent activity-dependent long-term changes or to facilitate extinction in pain-related systems are emerging.
Zieglgänsberger
W
W
Max-Planck-Institute of Psychiatry, Clinical Institute, München, Germany.
Tölle
T R
TR
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D004723:Endorphins / Q000502:physiology; D006801:Humans; D008954:Models, Biological; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009479:Neuropeptides / Q000502:physiology; D009619:Nociceptors / Q000502:physiology; D010146:Pain / Q000503:physiopathology*; D017470:Receptors, Glutamate / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology; D015398:Signal Transduction; D013116:Spinal Cord / Q000502:physiology* / Q000503:physiopathology
D000700:Analgesics; D004723:Endorphins; D009479:Neuropeptides; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate